Tommy M. Bunte

Utrecht, UT 3584CX, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial.

Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial.

Journal: Nature communications

Published: March 31, 2025

Respiratory measurements, respiratory symptoms, and quality of life in ALS: results from the REVEALS study.

Respiratory measurements, respiratory symptoms, and quality of life in ALS: results from the REVEALS study.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 06, 2025

REVEALS-a longitudinal cohort study of multifaceted respiratory assessment in ALS.

REVEALS-a longitudinal cohort study of multifaceted respiratory assessment in ALS.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: June 07, 2024

International network for ALS research and care (INARC).

International network for ALS research and care (INARC).

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: June 03, 2024

The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.

The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: February 24, 2024

Harmonized standard operating procedures for administering the ALS functional rating scale-revised.

Harmonized standard operating procedures for administering the ALS functional rating scale-revised.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: September 20, 2023

A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis.

A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis.

Journal: European journal of neurology

Published: May 26, 2023

Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALS.

Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALS.

Journal: Neurology

Published: December 08, 2022

Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures.

Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: December 24, 2021

Correlations between measures of ALS respiratory function: is there an alternative to FVC?

Correlations between measures of ALS respiratory function: is there an alternative to FVC?

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: September 30, 2021

A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial).

A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial).

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: July 07, 2020

Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort study.

Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort study.

Journal: Journal of neurology

Published: May 07, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026